Pacira BioSciences, Inc. (Nasdaq: PCRX) announced the issuance of inducement awards to seven new employees on July 2, 2025, under its Amended and Restated 2014 Inducement Plan. Approved by the People & Compensation Committee of the Board of Directors in accordance with Nasdaq Listing Rule 5635(c)(4), these awards were granted without stockholder approval. The package includes stock options for one employee to purchase 3,500 shares at an exercise price of $23.21 per share, with a 10-year term and a four-year vesting schedule. Additionally, seven employees received restricted stock units for a total of 12,300 shares, vesting annually over four years starting July 1, 2026. The vesting of these equity awards is contingent upon the employees' continued employment with Pacira.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。